(Q28253823)

https://api.crossref.org/works/10.1038%2FNRC3174

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Increased population prevalence of reflux and obesity in the United Kingdom compared with Sweden: a potential explanation for the difference in incidence of esophageal adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Childhood body mass index and later cancer risk: A 50-year follow-up of the Boyd Orr study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity and breast cancer: progress to understanding the relationship.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity is associated with macrophage accumulation in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Immunity, Inflammation, and Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

An endotoxin-induced serum factor that causes necrosis of tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Enhancement of experimental metastasis by tumor necrosis factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasminogen activation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Tumors as organs: complex tissues that interface with the entire organism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Positional cloning of the mouse obese gene and its human homologue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Selective deletion of leptin receptor in neurons leads to obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin and gastro-intestinal malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Molecular mechanisms of leptin and adiponectin in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin in relation to prostate cancer and benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Activation of downstream signals by the long form of the leptin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin is a growth factor for colonic epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin mediates a proliferative response in human MCF7 breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Leptin receptor signaling supports cancer cell metabolism through suppression of mitochondrial respiration in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

AdipoQ is a novel adipose-specific gene dysregulated in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasma adiponectin concentrations and risk of incident breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Circulating adiponectin and endometrial cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin as a growth inhibitor in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Biologically active sphingolipids in cancer pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Role of the adiponectin leptin ratio in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipokines and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity, adipokines, and lung disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipose tissue remodeling and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Adipose tissue-derived progenitor cells and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Organ targeting in vivo using phage display peptide libraries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

White fat progenitor cells reside in the adipose vasculature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Increased number of islet-associated macrophages in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Tumour-educated macrophages promote tumour progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

The role of myeloid cells in the promotion of tumour angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Lipid-induced insulin resistance: unravelling the mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

A prospective study of plasma C-peptide and colorectal cancer risk in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Selective versus total insulin resistance: a pathogenic paradox

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Involvement of insulin receptor substrate 2 in mammary tumor metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin and insulin-like growth factor signalling in neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Gene expression profiles in normal and cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Bioactive insulin-like growth factor-I in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Induction of the growth inhibitor IGF-binding protein 3 by p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

IGFBP2 promotes glioma tumor stem cell expansion and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Elevated insulin receptor content in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Overexpression of the insulin-like growth factor I receptor in human colon carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Hyperactive Ras in developmental disorders and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

mTOR: from growth signal integration to cancer, diabetes and ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Tumours with PI3K activation are resistant to dietary restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Fatty acid synthesis: a potential selective target for antineoplastic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Identification of a physiologically relevant endogenous ligand for PPARalpha in liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Peroxisome-Generated Hydrogen Peroxide as Important Mediator of Lipotoxicity in Insulin-Producing Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Life without white fat: a transgenic mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Long-term mortality after gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Cancer incidence and mortality after gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Risk of Obesity-Related Cancer After Obesity Surgery in a Population-Based Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Terminal differentiation of human breast cancer through PPAR gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Synergy between PPARgamma ligands and platinum-based drugs in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Biological mechanisms linking obesity and cancer risk: new perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC3174

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis

31 March 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Leptin is associated with increased prostate cancer risk: a nested case-referent study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

A morphological study of the adipocyte precursor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020

Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22113164

12 December 2020